public company

Walgreens Boots Alliance

Industry Health

A public pharmacy and retail-health company operating Walgreens and related pharmacy businesses. Walgreens is a central CVS competitor, but its opioid settlements, shareholder control, and sensitive pharmacy-data position make it a low-scoring health retailer.

Why this matters: Drugstores should be compared directly because customers are choosing between similar pharmacy, vaccination, retail, and data environments.

Letter grade F Malignant Medium confidence (AI) Rubric gcd-rubric-v1 Last reviewed May 11, 2026

Final Score -7* F - Malignant

FMALIGNANT-7 pts

* Tentative scaffolding score. Not human-checked or final.

Base Material11

Bonus+0

Cap35Ownership <= 2 and Governance <= 2

After Cap11

Penalties-18

!Not Verified

Represent this organization?

Request verification to have the evidence record checked against primary materials and organization-supplied documents. Verification does not buy a higher score; scores change only when review finds factual errors, omissions, or miscalibration.

Request verification

Evaluation Overview

F - Malignant

The score turns mainly on Market Conduct, with the largest penalty coming from Human Harm.

Strengths

Market Conduct2/5
Product Integrity2/5
Ownership1/10

Penalties

Human Harm-7
Toxic Products-4
Surveillance Capture-3
Accountability Opacity-2

Evidence state

ConfidenceMedium confidence (AI)
ThoroughnessDeveloped (AI)
Linked claims9
Direct axis claims9
Coverage9/15

Scoring Axes

Axis	Score	Why this score
Ownership ? Control rights: shareholder-dominated at 0, worker cooperative control at 10.	1 / 10	Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. That keeps Walgreens Boots Alliance low on Ownership: decisive control remains with shareholders, private owners, executives, or state insiders rather than affected people. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Governance ? Binding decision authority: centralized control at 0, democratic stakeholder control at 10.	1 / 10	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That keeps Walgreens Boots Alliance low on Governance: ordinary users, workers, customers, or affected communities cannot change the rules that govern them. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Extraction ? Surplus allocation, wage share, CEO pay ratio, margins, and structured extraction judgment.	1 / 10	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That keeps Walgreens Boots Alliance low on Extraction: the business model makes extraction from workers, users, suppliers, customers, or the public central rather than incidental. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Labor Sovereignty ? Worker power: coercive conditions at 0, co-determination or ownership at 7. Employee dissatisfaction matters only when source-backed evidence shows concrete limits on worker agency, such as coercive scheduling, retaliation, wage theft, harassment, unsafe conditions, suppression of worker voice, or extreme turnover.	1 / 7	Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. That keeps Walgreens Boots Alliance low on Labor Sovereignty: labor remains managerially controlled, replaceable, or exposed to coercive employment and contracting conditions. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Solidarity with the Unemployed ? Treatment of exits and nonworkers, including severance, redeployment, and non-competes.	1 / 7	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That keeps Walgreens Boots Alliance low on Solidarity with the Unemployed: the model provides little protection for people who leave, are excluded, or cannot bargain from employment. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Loss-Bearing Fidelity ? Willingness to absorb costs to preserve values, workers, users, and public obligations.	1 / 7	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That keeps Walgreens Boots Alliance low on Loss-Bearing Fidelity: losses, hazards, or adjustment costs are routinely pushed onto workers, customers, suppliers, communities, or the public. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Market Conduct ? Pricing fairness, switching costs, lock-in, and rent extraction.	2 / 5	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That places Walgreens Boots Alliance in the middle of Market Conduct: the product has real value but still uses meaningful lock-in, gatekeeping, market power, or dependency. The value stays below the top tier because the linked record does not show full democratic control, non-extractive lock-in, or complete stakeholder protection on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Product Integrity ? Preservation of quality rather than degradation for monetization.	2 / 5	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That places Walgreens Boots Alliance in the middle of Product Integrity: the product has real use value but is compromised by incentives, monetization, lock-in, quality degradation, or risk. The value stays below the top tier because the linked record does not show full democratic control, non-extractive lock-in, or complete stakeholder protection on this axis. Linked evidence Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Scale Integrity ? Whether growth improves or degrades fairness and accountability.	1 / 5	Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. That keeps Walgreens Boots Alliance low on Scale Integrity: scale magnifies harm, gatekeeping, opacity, or extraction rather than disciplining it. The value is above zero only where the linked record still shows some real function, constraint, or public value on this axis. Linked evidence context Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods. [1] context Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance. [2] context Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management. [3] context The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4] context Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5] context Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6] context Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]

Penalties

Penalty	Applied	Why this penalty
Human Harm ? Severity, scale, culpability, vulnerable targets, willful reoffense, reputation laundering, pattern escalation, and time decay. Range: -20 to 0.	-7	The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. That warrants a substantial Human Harm penalty because ordinary operation, documented misconduct, or institutional power creates serious injury, deprivation, abuse, or foreseeable human damage. The value is substantial but not at the floor because the linked record shows serious conduct without the strongest aggravating factors on this axis. Linked evidence The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory. [4]
Ecological Harm ? Footprint, trajectory, irreversibility, culpability, and scale, including whether ecological harm is central to the model and continued after credible notice. Range: -30 to 0.	-1	The competitor-coverage pass applies an Ecological Harm penalty because the entity's core operations depend on high-volume transport, retail, fuel, facilities, packaging, or other environmentally burdensome activity. The competitor-coverage pass applies an Ecological Harm penalty because the entity's core operations depend on high-volume transport, retail, fuel, facilities, packaging, or other environmentally burdensome activity. That warrants a limited Ecological Harm penalty because the institution causes or defends ecological damage that is more than incidental to the model. The value is limited because the linked record shows a real problem but not one that dominates the profile on this axis. Linked evidence The competitor-coverage pass applies an Ecological Harm penalty because the entity's core operations depend on high-volume transport, retail, fuel, facilities, packaging, or other environmentally burdensome activity. [8]
Toxic Products ? Current sale of products whose ordinary use, exposure, ingredients, residues, packaging, or formulation creates toxic, addictive, or consumer-safety risk. Food products receive at least light scrutiny for artificial colors, artificial flavors, petro-derived additives, pesticide residues, contaminants, endocrine-disrupting packaging, and ultra-processed formulation. Ordinary adult nightlife or alcohol service is not penalized by itself without evidence of predatory marketing, youth targeting, addiction-extractive design, or unusual product-safety misconduct. Range: -5 to 0.	-4	Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. That warrants a severe Toxic Products penalty because ordinary use, exposure, ingredients, residues, packaging, or formulation creates material toxic, addictive, or consumer-safety risk. The value is near the floor because the conduct appears central, large-scale, repeated, or institutionally powerful rather than incidental. Linked evidence Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access. [5]
Accountability Opacity ? Material opacity, reputation laundering, or hidden accountability structures that prevent public accountability. Range: -2 to 0.	-2	Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. That warrants a severe Accountability Opacity penalty because material facts, risks, conflicts, ownership, or accountability information are obscured from the public. The value is near the floor because the conduct appears central, large-scale, repeated, or institutionally powerful rather than incidental. Linked evidence Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate. [7]
Surveillance Capture ? Invasive surveillance, unreasonably non-optional tracking, facial recognition, biometric identification, or AI behavior scanning of customers, workers, bystanders, or the public. Range: -5 to 0.	-3	Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. That warrants a substantial Surveillance Capture penalty because customers, workers, users, bystanders, or the public are exposed to invasive tracking, biometrics, or behavior scanning. The value is substantial but not at the floor because the linked record shows serious conduct without the strongest aggravating factors on this axis. Linked evidence Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass. [6]
Ideological Disavowal ? Concealed ideology presented as neutrality, expertise, professional necessity, public-service administration, market inevitability, or non-ideological common sense while exercising power. Range: -3 to 0.	-1	The competitor-coverage pass applies an Ideological Disavowal penalty because the entity presents ordinary investor-centered market governance, surveillance, or risk-pricing choices as… The competitor-coverage pass applies an Ideological Disavowal penalty because the entity presents ordinary investor-centered market governance, surveillance, or risk-pricing choices as neutral service administration rather than as contested institutional choices. That warrants a limited Ideological Disavowal penalty because the institution presents situated, contested choices as neutrality, expertise, inevitability, safety, or common sense. The value is limited because the linked record shows a real problem but not one that dominates the profile on this axis. Linked evidence The competitor-coverage pass applies an Ideological Disavowal penalty because the entity presents ordinary investor-centered market governance, surveillance, or risk-pricing choices as neutral service administration rather than as contested institutional choices. [9]

Bonus Credits

No bonus credits applied in this version.

Confidence Basis

Confidence is computed from the evidence trail and review state, not typed into the profile by hand.

Medium 76/100

9 verified linked claims 9 direct axis claims 0 disputed claims 9/15 components covered

This confidence label measures the source-backed evidence trail. AI-scaffolded scores remain tentative until human review.

Claim confidence 16/20

9 verified linked claims

Source quality 16/18

Best source per verified claim, weighted by institutional reliability

Direct axis-specific claims 9/18

9 direct claims across 15 active components

Dispute load 12/12

0 disputed claims on this entity

Recency 10/10

Newest accepted timestamp: May 13, 2026

Reviewer status 7/12

Human-reviewed components score higher than AI scaffolding

Component coverage 6/10

9/15 evidence-bearing components have direct support

Evidence State

Profile stateAI draft / human-pending

VerificationUnverified

ConfidenceMedium confidence (AI)

ThoroughnessDeveloped (AI)

Correction routeUse “Challenge this rating” for factual errors, missing counterevidence, source problems, or calculation mistakes.

Company responseCompany representatives can submit source-backed corrections; payment never changes scores or reviewer authority.

Claims and Sources

Claims are the evidence record. Each claim needs a source link, axis category, status, confidence level, and timestamp before it can support a score.

* Tentative scaffolding score. Not human-checked or final.

1Walgreens Boots Alliance operates one of the largest U.S. pharmacy chains, selling prescriptions, health services, vaccinations, and retail goods.

Product Integrity Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens Boots Alliance SEC filingPrimary public record · 100%
Walgreens corporate siteGeneral web source · 58%

2Walgreens Boots Alliance is a shareholder-governed public company, so pharmacy and retail-health decisions are ultimately controlled through corporate and investor governance.

Ownership Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens Boots Alliance SEC filingPrimary public record · 100%

3Walgreens' pharmacy and retail labor structure is conventional corporate employment, with no worker ownership or stakeholder-control mechanism capable of overriding investor-centered management.

Labor Sovereignty Verified Medium confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens ESG Technical Report 2024General web source · 58%

4The Justice Department announced a settlement resolving allegations that Walgreens filled millions of invalid opioid and controlled-substance prescriptions and sought federal payment for many of them, while Walgreens disputed the government's legal theory.

Human Harm Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

DOJ/OIG Walgreens opioid settlement press releasePrimary public record · 100%
Axios Walgreens opioid settlementPrimary public record · 100%

5Walgreens' controlled-substance and opioid allegations make toxic-product risk material to the score, even though pharmacies also provide necessary medicines and public-health access.

Toxic Products Verified High confidence AI-generated / human-pending May 11, 2026

AI scaffold

DOJ/OIG Walgreens opioid settlement press releasePrimary public record · 100%

6Walgreens' pharmacy and healthcare operations necessarily handle sensitive health, prescription, payment, and customer data at large scale, creating a material surveillance-capture concern even without a single platform-style data scandal in this pass.

Surveillance Capture Verified Medium confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens ESG Technical Report 2024General web source · 58%

7Walgreens' formal disclosures do not make the practical risk tradeoffs of pharmacy data, retail health, opioid oversight, and corporate incentives easy for ordinary patients to evaluate.

Accountability Opacity Verified Medium confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens Boots Alliance SEC filingPrimary public record · 100%

8The competitor-coverage pass applies an Ecological Harm penalty because the entity's core operations depend on high-volume transport, retail, fuel, facilities, packaging, or other environmentally burdensome activity.

Ecological Harm Verified Medium confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens Boots Alliance SEC filingPrimary public record · 100%
Walgreens corporate siteGeneral web source · 58%

9The competitor-coverage pass applies an Ideological Disavowal penalty because the entity presents ordinary investor-centered market governance, surveillance, or risk-pricing choices as neutral service administration rather than as contested institutional choices.

Ideological Disavowal Verified Medium confidence AI-generated / human-pending May 11, 2026

AI scaffold

Walgreens Boots Alliance SEC filingPrimary public record · 100%
Walgreens corporate siteGeneral web source · 58%

Alternatives

Competitors

AGOOD66 Patient Advocate Foundation nonprofit patient case-management and financial-aid resource · same market AGOOD54 Federally Qualified Health Centers publicly supported community health-center system · same market AGOOD53 OpenNotes academic healthcare-transparency initiative · same market AGOOD50 CPESN USA network of independent community pharmacies · same market BQUALIFIED49 Civica Rx nonprofit generic medicine company · same market BQUALIFIED43 Planned Parenthood nonprofit reproductive and sexual healthcare federation · same market CPERFORMATIVE41 En-Vision America / ScriptAbility accessible prescription-labeling company · same market CPERFORMATIVE41 Mark Cuban Cost Plus Drug Company public-benefit online pharmacy · same market

Help Improve This Profile

Submit source-backed evidence or challenge a specific claim, source, axis value, or calculation below.

How This Page Is Maintained

Evidence comes in through contributors, is checked by verifiers, and is synthesized by reviewers. Founder authority remains narrow and visible; scores recalculate when verified claims or the rubric change.

Civic Note

Incorporation, limited liability, market access, and other institutional privileges are public grants. Good Companies Directory treats those privileges as conditional on accountability to workers, users, communities, and the public.

Submit evidence for Walgreens Boots Alliance Add one source-backed fact for review.

Challenge this rating Point to a specific score, claim, source, or calculation problem.

Audit Log

Recent public changes for this company or group. The full audit log is part of the Transparency record.

No company-specific audit entries have been published yet.

View Full Audit Log